Live feed
Filing
SC 13G/A
SC 13G/A0001104659-24-024912·LakeShore Biopharma Co., Ltd.
Schedule 13G ownership disclosure
LAKESHORE BIOPHARMA CO LTD
Security class unavailable · CUSIP: G9845F109
Event date: 2024-02-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 41.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-024912
- Form type
- SC 13G/A
- Filer
- LakeShore Biopharma Co., Ltd.
- CIK
- CIK 1946399
- Filed
- Feb 16, 2024
- Reporting period
- Feb 16, 2024
- Description
- Schedule 13G beneficial ownership